Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates

Journal of Virology

Volumn 89, Issue 4, 2015, Pages 2192-2200

  Rennick, Linda J ^a   de Vries, Rory D ^b   Carsillo, Thomas J ^a   Lemon, Ken ^c   van Amerongen, Geert ^b   Ludlow, Martin ^a   Nguyen, D Tien ^b   Yüksel, Selma ^b   Verburgh, R Joyce ^b   Haddock, Paula ^c   McQuaid, Stephen ^d   Duprex, W Paul ^a   de Swart, Rik L ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; MEASLES VACCINE; GREEN FLUORESCENT PROTEIN; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MACACA FASCICULARIS; MACROPHAGE; MALE; MEASLES; MEASLES VACCINATION; MUSCLE; NONHUMAN; OPEN READING FRAME; REVERSE GENETICS; TARGET CELL; VIROGENESIS; VIRUS GENOME; VIRUS RECOMBINANT; ANIMAL; GENETICS; IMMUNOLOGY; MEASLES VIRUS; REPORTER GENE; STAINING; VIROLOGY;

MACACA; MEASLES VIRUS; PRIMATES;

ANIMALS; DENDRITIC CELLS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; MACACA FASCICULARIS; MACROPHAGES; MALE; MEASLES VACCINE; MEASLES VIRUS; MUSCLES; STAINING AND LABELING; VACCINES, ATTENUATED;

EID: 84921635998     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02924-14     Document Type: Article

References (42)

1. Griffin DE. 2013. Measles virus, p 1042-1069. In Knipe DM, Howley PM (ed), Fields virology, 6th ed, vol 1. Lippincott/Williams & Wilkins Co, Philadelphia, PA.
2. Muller CP, Huiss S, Schneider F. 1996. Secondary immune responses in parents of children with recent measles. Lancet 348:1379-1380. http://dx.doi.org/10.1016/S0140-6736(05)65440-2.
3. de Swart RL. 2009. Measles studies in the macaque model. Curr Top Microbiol Immunol 330:55-72.
4. van Binnendijk RS, van der Heijden RW, Osterhaus AD. 1995. Monkeys in measles research. Curr Top Microbiol Immunol 191:135-148.
5. Kobune F, Takahashi H, Terao K, Ohkawa T, Ami Y, Suzaki Y, Nagata N, Sakata H, Yamanouchi K, Kai C. 1996. Nonhuman primate models of measles. Lab Anim Sci 46:315-320.
6. Lemon K, de Vries RD, Mesman AW, McQuaid S, van Amerongen G, Yuksel S, Ludlow M, Rennick LJ, Kuiken T, Rima BK, Geijtenbeek TB, Osterhaus AD, Duprex WP, de Swart RL. 2011. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 7:e1001263. http://dx.doi.org/10.1371/journal.ppat.1001263.
7. de Vries RD, Lemon K, Ludlow M, McQuaid S, Yuksel S, van Amerongen G, Rennick LJ, Rima BK, Osterhaus AD, de Swart RL, Duprex WP. 2010. In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J Virol 84:4714-4724. http://dx.doi.org/10.1128/JVI.02633-09.
8. + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3:e178. http://dx.doi.org/10.1371/journal.ppat.0030178.
9. de Vries RD, McQuaid S, van Amerongen G, Yuksel S, Verburgh RJ, Osterhaus AD, Duprex WP, de Swart RL. 2012. Measles immune suppression: lessons from the macaque model. PLoS Pathog 8:e1002885. http://dx.doi.org/10.1371/journal.ppat.1002885.
10. Enders JF, Peebles TC. 1954. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 86:277-286. http://dx.doi.org/10.3181/00379727-86-21073.
11. Enders JF, Katz SL, Milovanovic MV, Holloway A. 1960. Studies on an attenuated measles-virus vaccine. I. Development and preparation of the vaccine: techniques for assay of effects of vaccination. N Engl J Med 263: 153-159.
12. Schwarz AJ. 1962. Preliminary tests of a highly attenuated measles vaccine. Am J Dis Child 103 216-219.
13. de Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G. 2003. Progress toward measles eradication in the region of the Americas. J Infect Dis 187(Suppl 1):S102-S110. http://dx.doi.org/10.1086/368032.
14. Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL. 2014. Global control and regional elimination of measles, 2000-2012. MMWR Morbid Mortal Wkly Rep 63:103-107.
15. Griffin DE, Pan CH, Moss WJ. 2008. Measles vaccines. Front Biosci 13:1352-1370. http://dx.doi.org/10.2741/2767.
16. Valdespino-Gomez JL, Lourdes Garcia-Garcia M, Fernandez-de Castro J, Henao-Restrepo AM, Bennett J, Sepulveda-Amor J. 2006. Measles aerosol vaccination. Curr Top Microbiol Immunol 304:165-193.
17. Sabin AB, Fernandez de Castro J, Flores Arechiga A, Sever JL, Madden DL, Shekarchi I. 1982. Clinical trials of inhaled aerosol of human diploid and chick embryo measles vaccine. Lancet 320:604. http://dx.doi.org/10.1016/S0140-6736(82)90673-0.
18. El Mubarak HS, de Swart RL, Osterhaus AD, Schutten M. 2005. Development of a semi-quantitative real-time RT-PCR for the detection of measles virus. J Clin Virol 32:313-317. http://dx.doi.org/10.1016/j.jcv.2004.08.017.
19. El Mubarak HS, Yuksel S, van Amerongen G, Mulder PG, Mukhtar MM, Osterhaus AD, de Swart RL. 2007. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J Gen Virol 88:2028-2034. http://dx.doi.org/10.1099/vir.0.82804-0.
20. Stittelaar KJ, Wyatt LS, de Swart RL, Vos HW, Groen J, van Amerongen G, van Binnendijk RS, Rozenblatt S, Moss B, Osterhaus AD. 2000. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J Virol 74:4236-4243. http://dx.doi.org/10.1128/JVI.74.9.4236-4243.2000.
21. de Swart RL, Vos HW, UytdeHaag FG, Osterhaus AD, van Binnendijk RS. 1998. Measles virus fusion protein-and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay. J Virol Methods 71:35-44. http://dx.doi.org/10.1016/S0166-0934(97)00188-2.
22. Baricevic M, Forcic D, Gulija TK, Jug R, Mazuran R. 2005. Determination of the coding and non-coding nucleotide sequences of genuine Edmonston-Zagreb master seed and current working seed lot. Vaccine 23:1072-1078. http://dx.doi.org/10.1016/j.vaccine.2004.08.021.
23. Cattaneo R, Rebmann G, Schmid A, Baczko K, Ter Meulen V, Billeter MA. 1987. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J 6:681-688.
24. Mosca JD, Pitha PM. 1986. Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol Cell Biol 6:2279-2283.
25. Bankamp B, Takeda M, Zhang Y, Xu W, Rota PA. 2011. Genetic characterization of measles vaccine strains. J Infect Dis 204(Suppl 1): S533-S548. http://dx.doi.org/10.1093/infdis/jir097.
26. von Messling V, Milosevic D, Cattaneo R. 2004. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci USA 101:14216-14421. http://dx.doi.org/10.1073/pnas.0403597101.
27. Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima BK. 1999. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol 73:9568-9575.
28. Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi Y. 2002. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76:6743-6749. http://dx.doi.org/10.1128/JVI.76.13.6743-6749.2002.
29. Ludlow M, Nguyen DT, Silin D, Lyubomska O, de Vries RD, von Messling V, McQuaid S, De Swart RL, Duprex WP. 2012. Recombinant canine distemper virus strain Snyder Hill expressing green or red fluorescent proteins causes meningoencephalitis in the ferret. J Virol 86:7508-7519. http://dx.doi.org/10.1128/JVI.06725-11.
30. de Vries RD, Ludlow M, Verburgh RJ, van Amerongen G, Yuksel S, Nguyen DT, McQuaid S, Osterhaus AD, Duprex WP, de Swart RL. 2014. Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus. J Virol 88:4423-4433. http://dx.doi.org/10.1128/JVI.03676-13.
31. Walpita P. 2004. An internal element of the measles virus antigenome promoter modulates replication efficiency. Virus Res 100:199-211. http://dx.doi.org/10.1016/j.virusres.2003.12.025.
32. Rennick LJ, Duprex WP, Rima BK. 2007. Measles virus minigenomes encoding two autofluorescent proteins reveal cell-to-cell variation in reporter expression dependent on viral sequences between the transcription units. J Gen Virol 88:2710-2718. http://dx.doi.org/10.1099/vir.0.83106-0.
33. Lorin C, Mollet L, Delebecque F, Combredet C, Hurtrel B, Charneau P, Brahic M, Tangy F. 2004. A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J Virol 78:146-157. http://dx.doi.org/10.1128/JVI.78.1.146-157.2004.
34. del Valle JR, Devaux P, Hodge G, Wegner NJ, McChesney MB, Cattaneo R. 2007. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol 81:10597-10605. http://dx.doi.org/10.1128/JVI.00923-07.
35. Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A. 2014. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection. J Virol 88: 4237-4250. http://dx.doi.org/10.1128/JVI.03481-13.
36. Griffin DE, Pan C-H. 2009. Measles: old vaccines, new vaccines. Curr Top Microbiol Immunol 330:191-212.
37. World Health Organization. 2009. Measles vaccines: WHO position paper. Wkly Epidemiol Rec 84:349-360.
38. Gillet Y, Habermehl P, Thomas S, Eymin C, Fiquet A. 2009. Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial. BMC Med 7:16. http://dx.doi.org/10.1186/1741-7015-7-16.
39. Buckland R, Wild TF. 1997. Is CD46 the cellular receptor for measles virus? Virus Res 48:1-9. http://dx.doi.org/10.1016/S0168-1702(96)01421-9.
40. Liszewski MK, Atkinson JP. 1992. Membrane cofactor protein. Curr Top Microbiol Immunol 178:45-60.
41. Takeuchi K, Nagata N, Kato SI, Ami Y, Suzaki Y, Suzuki T, Sato Y, Tsunetsugu-Yokota Y, Mori K, Van Nguyen N, Kimura H, Nagata K. 2012. Wild-type measles virus with the hemagglutinin protein of the edmonston vaccine strain retains wild-type tropism in macaques. J Virol 86:3027-3037. http://dx.doi.org/10.1128/JVI.06517-11.
42. Schutsky K, Curtis D, Bongiorno EK, Barkhouse DA, Kean RB, Dietzschold B, Hooper DC, Faber M. 2013. Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies. J Virol 87:1834-1841. http://dx.doi.org/10.1128/JVI.02589-12.